Why is Trident Texofab falling/rising?

As of 28-Aug, Trident Texofab Ltd's stock price is rising, currently at Rs 246.75, reflecting an increase of Rs 9.3 or 3.92%. The stock reached a new 52-week and all-time high of Rs 248.85 today, outperforming its sector by 3.63%. It opened with a gain of 3.35% and touched an intraday high of Rs 248.85, indicating strong investor interest. Over the past week, the stock has risen by 8.70%, and it has shown impressive returns of 428.37% over the last year, significantly outperforming the BSE500 benchmark, which has declined by 2.08% during the same period. The company has reported positive results for the last three consecutive quarters, with net sales growing by 24.20%, contributing to the stock's upward momentum.
Broader Market Context: In contrast to the broader market, which has seen a decline of 2.34% over the past week, Trident Texofab's strong performance highlights its resilience and appeal among investors. The stock's liquidity is sufficient for trading, and the increase in delivery volume suggests rising investor participation. Additionally, the company’s consistent profitability and positive operational metrics further bolster investor confidence, making it a compelling choice in a challenging market environment.